(Q40749254)

23 September 2017

title

Inhibition of metalloproteinases enhances the internalization of anti-CD30 antibody Ki-3 and the cytotoxic activity of Ki-3 immunotoxin (English)

1 reference

23 September 2017

3

1 reference

23 September 2017

Hinrich P Hansen

1

1 reference

23 September 2017

Bärbel Matthey

2

1 reference

23 September 2017

Tatiana Kisseleva

4

1 reference

23 September 2017

Thilo Mokros

5

1 reference

23 September 2017

Stephen J Davies

6

1 reference

23 September 2017

R Paul Beckett

7

1 reference

23 September 2017

Regina Foelster-Holst

8

1 reference

23 September 2017

Hans H Lange

9

1 reference

23 September 2017

Andreas Engert

10

1 reference

23 September 2017

Hilmar Lemke

11

1 reference

23 September 2017

language of work or name

English

0 references

publication date

1 March 2002

1 reference

International Journal of Cancer

23 September 2017

published in

1 reference

23 September 2017

volume

98

1 reference

23 September 2017

issue

2

1 reference

23 September 2017

page(s)

210-215

1 reference

Anti-CD30 antibody-based therapy

23 September 2017

cites work

1 reference

Ki-1 (CD30) antigen is released by Ki-1-positive tumor cells in vitro and in vivo. I. Partial characterization of soluble Ki-1 antigen and detection of the antigen in cell culture supernatants and in serum by an enzyme-linked immunosorbent assay

21 January 2018

1 reference

Impact of antigenemia on the bioactivity of infused anti-Tac antibody: implications for dose selection in antibody immunotherapies

21 January 2018

1 reference

Shedding of the soluble form of CD30 from the Hodgkin-analogous cell line L540 is strongly inhibited by a new CD30-specific antibody (Ki-4).

21 January 2018

1 reference

Membrane protein secretases

21 January 2018

1 reference

A metalloprotease-disintegrin, MDC9/meltrin-gamma/ADAM9 and PKCdelta are involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor.

21 January 2018

1 reference

The ADAM gene family: surface proteins with adhesion and protease activity

21 January 2018

1 reference

Results of single and repeat dose studies of the oral matrix metalloproteinase inhibitor marimastat in healthy male volunteers

21 January 2018

1 reference

Production of a monoclonal antibody specific for Hodgkin and Sternberg–Reed cells of Hodgkin's disease and a subset of normal lymphoid cells

21 January 2018

1 reference

Processing of tumour necrosis factor-α precursor by metalloproteinases

21 January 2018

1 reference

Development of new ricin A‐chain immunotoxins with potent anti‐tumor effects against human hodgkin cells in vitro and disseminated Hodgkin tumors in scid mice using high‐affinity monoclonal antibodies directed against the CD30 antigen

21 January 2018

1 reference

Serum levels of the soluble form of CD30 molecule as a tumor marker in CD30+ anaplastic large-cell lymphoma

21 January 2018

1 reference

Immunotoxins: magic bullets or misguided missiles?

21 January 2018

1 reference

CD30 shedding from Karpas 299 lymphoma cells is mediated by TNF-alpha-converting enzyme

21 January 2018

1 reference

CD30 antigen in non-Hodgkin's lymphoma

21 January 2018

1 reference

A zinc metalloproteinase is responsible for the release of CD30 on human tumor cell lines

21 January 2018

1 reference

Serum levels of soluble CD30 molecule (Ki-1 antigen) in Hodgkin's disease: relationship with disease activity and clinical stage

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.10182

1 reference

23 September 2017

1 reference